Literature DB >> 25645853

Thermosensitive and mucoadhesive pluronic-hydroxypropylmethylcellulose hydrogel containing the mini-CD4 M48U1 is a promising efficient barrier against HIV diffusion through macaque cervicovaginal mucus.

Kawthar Bouchemal1, Armelle Aka-Any-Grah2, Nathalie Dereuddre-Bosquet3, Loïc Martin4, Vanessa Lievin-Le-Moal5, Roger Le Grand3, Valérie Nicolas6, Davide Gibellini7, David Lembo8, Christian Poüs9, Armand Koffi10, Gilles Ponchel11.   

Abstract

To be efficient, vaginal microbicide hydrogels should form a barrier against viral infections and prevent virus spreading through mucus. Multiple particle tracking was used to quantify the mobility of 170-nm fluorescently labeled COOH-modified polystyrene particles (COOH-PS) into thermosensitive hydrogels composed of amphiphilic triblock copolymers with block compositions EOn-POm-EOn (where EO refers to ethylene oxide and PO to propylene oxide) containing mucoadhesive hydroxypropylmethylcellulose (HPMC). COOH-PS were used to mimic the size and the surface charge of HIV-1. Analysis of COOH-PS trajectories showed that particle mobility was decreased by Pluronic hydrogels in comparison with cynomolgus macaque cervicovaginal mucus and hydroxyethylcellulose hydrogel (HEC; 1.5% by weight [wt%]) used as negative controls. Formulation of the peptide mini-CD4 M48U1 used as an anti-HIV-1 molecule into a mixture of Pluronic F127 (20 wt%) and HPMC (1 wt%) did not affect its anti-HIV-1 activity in comparison with HEC hydrogel. The 50% inhibitory concentration (IC50) was 0.53 μg/ml (0.17 μM) for M48U1-HEC and 0.58 μg/ml (0.19 μM) for M48U1-F127-HPMC. The present work suggests that hydrogels composed of F127-HPMC (20/1 wt%, respectively) can be used to create an efficient barrier against particle diffusion in comparison to conventional HEC hydrogels.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25645853      PMCID: PMC4356805          DOI: 10.1128/AAC.03503-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  30 in total

1.  In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials.

Authors:  Deborah Tien; Roger L Schnaare; Feirong Kang; Gina Cohl; Timothy J McCormick; Thomas R Moench; Gustavo Doncel; Karen Watson; Robert W Buckheit; Mark G Lewis; Jill Schwartz; Karen Douville; Joseph W Romano
Journal:  AIDS Res Hum Retroviruses       Date:  2005-10       Impact factor: 2.205

2.  Modulation of the rheological and mucoadhesive properties of thermosensitive poloxamer-based hydrogels intended for the rectal administration of quinine.

Authors:  A A Koffi; F Agnely; G Ponchel; J L Grossiord
Journal:  Eur J Pharm Sci       Date:  2005-12-13       Impact factor: 4.384

3.  Feature point tracking and trajectory analysis for video imaging in cell biology.

Authors:  I F Sbalzarini; P Koumoutsakos
Journal:  J Struct Biol       Date:  2005-08       Impact factor: 2.867

4.  Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus.

Authors:  Samuel K Lai; D Elizabeth O'Hanlon; Suzanne Harrold; Stan T Man; Ying-Ying Wang; Richard Cone; Justin Hanes
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-23       Impact factor: 11.205

Review 5.  Microchannel enzyme reactors and their applications for processing.

Authors:  Masaya Miyazaki; Hideaki Maeda
Journal:  Trends Biotechnol       Date:  2006-08-28       Impact factor: 19.536

6.  CD4 mimetic miniproteins: potent anti-HIV compounds with promising activity as microbicides.

Authors:  Yven Van Herrewege; Laurence Morellato; Anne Descours; Laetitia Aerts; Jo Michiels; Leo Heyndrickx; Loïc Martin; Guido Vanham
Journal:  J Antimicrob Chemother       Date:  2008-02-12       Impact factor: 5.790

7.  A concise analysis of the effect of temperature and propanediol-1, 2 on Pluronic F127 micellization using isothermal titration microcalorimetry.

Authors:  Kawthar Bouchemal; Florence Agnely; Armand Koffi; Gilles Ponchel
Journal:  J Colloid Interface Sci       Date:  2009-06-06       Impact factor: 8.128

8.  Antibody diffusion in human cervical mucus.

Authors:  W M Saltzman; M L Radomsky; K J Whaley; R A Cone
Journal:  Biophys J       Date:  1994-02       Impact factor: 4.033

9.  Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells.

Authors:  T Lesuffleur; A Barbat; E Dussaulx; A Zweibaum
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

10.  Combinatorial optimization of a CD4-mimetic miniprotein and cocrystal structures with HIV-1 gp120 envelope glycoprotein.

Authors:  François Stricher; Chih-chin Huang; Anne Descours; Sophie Duquesnoy; Olivier Combes; Julie M Decker; Young Do Kwon; Paolo Lusso; George M Shaw; Claudio Vita; Peter D Kwong; Loïc Martin
Journal:  J Mol Biol       Date:  2008-07-01       Impact factor: 5.469

View more
  7 in total

1.  Supramolecular Chitosan Micro-Platelets Synergistically Enhance Anti-Candida albicans Activity of Amphotericin B Using an Immunocompetent Murine Model.

Authors:  Tiphany Grisin; Christian Bories; Martina Bombardi; Philippe M Loiseau; Valérie Rouffiac; Audrey Solgadi; Jean-Maurice Mallet; Gilles Ponchel; Kawthar Bouchemal
Journal:  Pharm Res       Date:  2017-02-06       Impact factor: 4.200

2.  Thermosensitive Polymer Blend Composed of Poloxamer 407, Poloxamer 188 and Polycarbophil for the Use as Mucoadhesive In Situ Gel.

Authors:  Namon Hirun; Pakorn Kraisit; Vimon Tantishaiyakul
Journal:  Polymers (Basel)       Date:  2022-04-29       Impact factor: 4.967

3.  Opening the HIV envelope: potential of CD4 mimics as multifunctional HIV entry inhibitors.

Authors:  Annemarie Laumaea; Amos B Smith; Joseph Sodroski; Andrés Finzi
Journal:  Curr Opin HIV AIDS       Date:  2020-09       Impact factor: 4.283

Review 4.  Baseline and time-updated factors in preclinical development of anionic dendrimers as successful anti-HIV-1 vaginal microbicides.

Authors:  Ignacio Rodríguez-Izquierdo; Daniel Sepúlveda-Crespo; Jose María Lasso; Salvador Resino; Ma Ángeles Muñoz-Fernández
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2022-01-12

5.  M48U1 and Tenofovir combination synergistically inhibits HIV infection in activated PBMCs and human cervicovaginal histocultures.

Authors:  Giuseppina Musumeci; Isabella Bon; David Lembo; Valeria Cagno; Maria Carla Re; Caterina Signoretto; Erica Diani; Lucia Lopalco; Claudia Pastori; Loïc Martin; Gilles Ponchel; Davide Gibellini; Kawthar Bouchemal
Journal:  Sci Rep       Date:  2017-02-01       Impact factor: 4.379

Review 6.  High Preventive Effect of G2-S16 Anionic Carbosilane Dendrimer against Sexually Transmitted HSV-2 Infection.

Authors:  Ignacio Rodriguez-Izquierdo; Samanta Gasco; Maria Angeles Muñoz-Fernández
Journal:  Molecules       Date:  2020-06-28       Impact factor: 4.411

Review 7.  Emerging Role of Hydrogels in Drug Delivery Systems, Tissue Engineering and Wound Management.

Authors:  Shery Jacob; Anroop B Nair; Jigar Shah; Nagaraja Sreeharsha; Sumeet Gupta; Pottathil Shinu
Journal:  Pharmaceutics       Date:  2021-03-08       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.